Community Based Surveillance for AMR Monitoring: Significance, Requirements and Feasibility in LMICS
By Afreenish Amir
Community based surveillance, in addition to clinical antimicrobial resistance (AMR) surveillance, plays an essential role in AMR and antimicrobial use trend monitoring. Various community-based AMR surveillance studies to monitor trends in AMR and use of antimicrobials have been conducted and shown its potential to facilitate evidence-based interventions and policy making for control of AMR. Many low and middle income countries (LMICs) lack the necessary systems and resources to establish effective surveillance systems. Specifically, the surveillance capacity at hospitals and other health facilities is limited, and the overall human resource capacity for community-level data collection, analysis, and multi-sectoral coordination is severely constrained. Prior to planning for community based AMR surveillance, a country should have established mechanisms to run the system efficiently, including strong governance and regulations, surveillance infrastructure, laboratory capacities, skilled human resources, data collection and management, funding and sustainability.
The World Health Organization and quadripartite partners have recommended advancing community based AMR surveillance in LMICs, and integrated AMR surveillance combining information from humans, animals and ecosystems, which seems a challenge in the current situation. Considering the significant gaps in systems, resources, and capacities, it is important to prioritize strengthening the country’s core capacities and addressing the underlying gaps in healthcare systems. Efforts should focus on enhancing the country’s core capacities, systems, and technical requirements while exploring the potential of advancing selective community based AMR surveillance interventions and systems in the future.
Gender Intersectionality in Antimicrobial Resistance
Webinar Report
The South Centre held a webinar on Gender Intersectionality in Antimicrobial Resistance (AMR), on 14 May 2025, with the participation of experts from academia, independent research institutions and international organizations. The webinar was attended by over 70 participants from around the world, demonstrating interest in gaining greater understanding of the gender dimension in effective strategies fortackling antimicrobial resistance.
Designing an Independent Panel onEvidence for Action on Antimicrobial Resistance: Lessons from Selected Bodies in Global Health, Climate Change and Biodiversity
By Viviana Munoz Tellez and Francesca Chiara
This paper proposes a framework for designing an Independent Panel on Evidence for Action on Antimicrobial Resistance (IPEA), responding to the 2025 United Nations General Assembly mandate. Through a comparative analysis of selected international scientific advisory bodies, we identify the panel’s mandate as the foundational element that will critically shape its composition, scope, deliverables, and governance structure. Our framework addresses key domains of credibility, scientific integrity, authority, policy relevance, and sustainability while establishing equity as a fundamental design principle—not merely ensuring low and middle-income country (LMIC) participation but designing the IPEA to address existing imbalances in antimicrobial resistance (AMR) evidence production and dissemination. We analyse potential mandate options, from evidence synthesis to policy recommendations, highlighting the importance of defining a unique and complementary role for IPEA within the existing AMR governance landscape to avoid duplication and maximize impact on global AMR response.
Policy in Practice: Implementing Antimicrobial Stewardship Post-COVID-19
Q&A and Commentary
By Dr Rasha Abdelsalam Elshenawy
This report summarises the key questions and expert commentary for the South Centre, as well as the South Centre Policy Brief on lessons from the COVID-19 pandemic, to strengthen antimicrobial stewardship and provide practical recommendations discussed during the South Centre webinar on “Strengthening Antimicrobial Stewardship: Policy Insights from COVID-19 and Future Pandemic Preparedness.”
ID with the SR on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health
South Centre Statement (Item 3)
In its 59th session of the Human Rights Council statement on the Right to Health, the South Centre addressed the Special Rapporteur’s report, focusing on the protection of health and care workers. The statement noted the challenges they face, from migration impacts to poor working conditions, and called for their protection to ensure health equity for all.
Advancing Women and Girls’ Health in a Time of Converging Crises
South Centre Briefing Session (April 2025) Report
The South Centre hosted a high-level briefing session aimed at advancing the health rights of women and girls in the face of multiple global challenges. The meeting coincided with the South Centre’s 30th anniversary and the 30th anniversary of the Beijing Declaration and Platform for Action, bringing together ambassadors, health experts, and representatives of international organisations to discuss the protection and advancement of sexual and reproductive health and rights (SRHR) in the Global South.
Sexual and Reproductive Health and Rights in the Context of International Human Rights
By Carlos Correa and Daniel Uribe
This policy brief examines the growing recognition of sexual and reproductive health and rights (SRHR) within the framework of international human rights law. It traces the evolution of this consensus through key United Nations (UN) General Assembly and Human Rights Council resolutions, foundational documents like the International Conference on Population and Development (ICPD) Programme of Action and the Beijing Platform for Action, and the interpretative work of human rights treaty bodies. These instruments increasingly affirm that SRHR are an integral component of the right to health and are essential for gender equality. However, this brief also highlights the challenges these common efforts face in line with other views, which prioritise national sovereignty in determining policies on reproductive health. The analysis highlights the tension between the evolving international human rights framework and state-centric approaches, concluding with the imperative for ongoing dialogue to solidify and implement SRHR as universal, inalienable human rights.
Access to medical products and reproductive rights
Side Event to the 59th Session of the Human Rights Council
23 June 2025
12:00 to 13:00
Room XXVII, Palais de Nations, Geneva, Switzerland
The pursuit of health equity, encompassing fair and just opportunities for all to achieve their full health potential, remains a paramount global challenge. The right to health is a fundamental part of our human rights and of our understanding of a life in dignity. This event will explore the indivisible links between equitable access to medical products, the advancement of sexual and reproductive health and rights (SRHR), and the strengthening of international cooperation as pillars for upholding this fundamental right for everyone, everywhere. The interconnectedness of these themes is central; they are not disparate issues but integral components of a holistic approach necessary to realise comprehensive health equity.
The side event is anticipated to significantly enhance participants’ understanding of the complex, intersecting challenges and opportunities in upholding health equity, particularly through improved access to medical products and the full realization of SRHR. The discussions aim to identify potential policy pathways, innovative approaches, and actionable strategies for key stakeholders to address existing inequities. Furthermore, a crucial outcome will be a reinforced commitment to multilateralism and collaborative action as essential tools for tackling global health challenges and advancing the right to health, with the dialogue contributing valuable insights to ongoing policy debates in relevant international fora, especially concerning the implementation of recent global agreements and agendas, while also strengthening networks and partnerships dedicated to health equity and human rights.
Scope of Compulsory License and Government Use of Patented Medicines
To meet public health needs governments can use compulsory licenses and government use as a tool for procurement and import of patented medicines. These mechanisms are provided for in most laws worldwide. The WTO TRIPS Agreement, as reaffirmed by the Doha Declaration on TRIPS and Public Health, recognises the right of WTO members to grant compulsory licenses and their freedom to determine the grounds upon which such licenses may be granted.
This table provides information of instances of their use.
From global to local action: Operationalising AMR commitments in Africa and beyond
11-12 June 2025
Lusaka, Zambia
The ReAct Africa-South Centre Annual Conference 2025 aims to translate these global and regional commitments into actionable strategies for local and national contexts in low- and middle-income countries; with a specific focus on Africa’s needs and priorities. It will serve as a platform for key stakeholders from, but not limited to governments at the regional, national and sub-national levels
A great variety of stakeholders will join the conference in Lusaka: International & regional organizations (Quadripartite organs – FAO, WHO, WOAH & UNEP; Africa CDC, ECSA-HC, etc.), public health professionals and health practitioners, civil society and community organizations, academia and research institutions, youth in AMR, faith sector, private sector leaders and innovators, media and communication experts.
INTERNSHIP PROGRAMME – STRENGTHENING THE RIGHT TO HEALTH
The South Centre is seeking to fill internship positions to support its activities in the area of strengthening the right to health from a perspective of countries of the Global South.
Specific intern responsibilities include, but are not limited to, supporting the Strengthening the Right to Health project.
